Navigation Links
PPARGamma-Competitor Assay Kit Green from Invitrogen

ProductsPPARGamma-Competitor Assay Kit Green from Invitrogen
Company Invitrogen
Item PPARGamma-Competitor Assay Kit Green
Price 
Description Peroxisome Proliferator-Activated Receptor-gamma (PPAR) is a member of a nuclear receptor family of ligand-activated transcription factors that heterodimerize with retinoic acid-like receptor (RXR). It is involved in the regulation of glucose and lipid metabolism. Agonists include the (TZD) class of anti-diabetic agents called thiazolidinediones (TZD) or "glitazones." Rosiglitazone (Avandia) and Pioglitazone (Actos) are two PPAR agonists currently marketed for treatment of type 2 diabetes. PPAR agonists may also be therapeutically important in the treatment of coronary artery disease, obesity, and cancer.


The Peroxisome Proliferator-Activated Receptor-gamma (PPAR) Competitor Assay Kit, Green provides a sensitive and efficient method for studying and screening potential PPAR ligands using fluorescence polarization (FP). The kit contains human PPAR 1-ligand binding domain (PPAR-LBD) with an N-terminal His-tag and a novel, selective fluorescent PPAR ligand (Fluormone PPAR Green) in a homogenous mix-and-read assay format.


Assay mechanism:
PPAR-LBD is added to Fluormone PPAR Green to form a PPAR-LBD/Fluormone PPAR Green complex. Binding of the PPAR-LBD to the Fluormone PPAR Green ligand results in a high polarization value. This complex is then added to individual test compounds in microwell plates. Competitors displace the Fluormone PPAR Green ligand from the PPAR-LBD/Fluormone PPAR Green complex, causing the Fluormone PPAR Green ligand to tumble rapidly during its fluorescent lifetime and resulting in a low polarization value. Non-competitors will not displace the Fluormone PPAR Green ligand from the complex, so the polarization value remains high. The shift in polarization value in the presence of test compounds is used to determine the relative affinity of test compounds for PPAR-LBD.


Contents:
The PPAR-Competitor Assay Kit, Green includes purified, active PPAR-LBD protein, Fluormone PPAR Green ligand, and assay buffer
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PolarScreen PPARGamma-Competitor Assay Kit, Red from Molecular Probes (Invitrogen)
2. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
3. In Vitro Osteogenesis Assay Kit from CHEMICON
4. Mast Cell Degranulation colorimetric Assay Kit from CHEMICON
5. PR Competitor Assay Green from Invitrogen
6. PolarScreen Androgen Receptor Competitor Assay Kit, Red from Molecular Probes (Invitrogen)
7. Hydrogen Peroxide / Peroxidase Fluorometric (resorufin) Assay Kit, Fluoro H2O2 from BACHEM
8. Total antioxidant capacity Colorimetric Assay Kit from Neogen Corporation
9. PolarScreen Progesterone Receptor Competitor Assay Kit, Far Red from Molecular Probes (Invitrogen)
10. Total Antioxidant Power Colorimetric Assay Kit from Neogen Corporation
11. NDPase (GDPase, UDPase, ADPase) Assay Kit from Sigma-Aldrich
... value of your microarray data using Asuragens bio...ed from consultation to extensive data analysis us...tise in combination with the Gene Expression Profi...ts., ,Normalization and basic statistical anal...
CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich
... (OSM) is a pleiotropic cytokine produced by activ.... OSM inhibits the growth of some tumour and norma...and Kaposis sarcoma cell proliferation, cytokine r...protein receptor expression on hepatoma cells. Mou...
...syringe pump series combines Harvard Apparatuss be...ce and a wide range of configuration options. A lo...nsions of syringes from all the major manufacturer...e pertinent information from across the lab. All m...
Biology Products:
(Date:11/25/2009)... the Cell Death Research Laboratory in the Univers...rded the prestigious Johnson & Johnson Focused Fun... brain cell damage in Parkinson,s disease. The awa...pport of innovation and excellence in science, was...er this month at an event at the Hyatt Regency Hot...
(Date:11/25/2009)...e, the heart pumps some 250 million liters of bloo...uscle fibers of the heart have to be extremely dur...ttbauer, vice chair of the Department of Medicine ...rof. Dr. H. A. Katus), has discovered a protein th...t muscular unit, the sarcomere. In cooperation wit...
(Date:11/25/2009)...ay be just as vital to your health as what you eat...ogical Studies. Their experiments in mice revealed...genes in the liverthe body,s metabolic clearinghou...he body,s circadian clock as conventional wisdom h...ty of a large number of genes completely independe...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 1CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 2CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 1KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 4KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 5KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 6A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2
...optimize the cardiac function of patients with hea...atients might be at higher risk of dying suddenly ...ke University Medical Center. , Besides maintainin...se CRT-D (cardiac resynchronization therapy with d...new view of subtle changes in a key measurement of...
...f Liverpool have discovered how fish have evolved ... at different water depths. , A research team led...ist at the School of Biological Sciences, has reve...eveloped a way of floating at certain water levels...nvestigated the mechanism that allows fishes to ke...
...iversity scientists have "programmed" cells to mak...d high-resolution, deep-tissue imaging of gene exp... of Nature Medicine, hold considerable promise for...eld of molecular therapeutics and for monitoring t...or 20 years it has been the chemist,s job to devel...
Other Biology News:Implanted Devices Detect High-Risk Heart Failure Patients 2Implanted Devices Detect High-Risk Heart Failure Patients 3Scientists discover how fish evolved to float at different sea depths 2Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals 2
(Date:11/24/2009)... The FBI recently approved the Promega PowerPl...ing in or generating DNA records for the National ...on, WI USA (PRWEB) -- The FBI recently approved th... laboratories participating in, or generating DNA ... NDIS currently contains more than seven million p...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASD...pany,today,announcedthatithassubmittedaMAAtotheEur...ny,senzymereplacementtherapyindevelopment,forthetr...ng,applicationforvelaglucerasealfathathasbeensubmi...anada. , Basedonaglobalsupplyshortageofthecur...
(Date:11/24/2009)...ovember24/PRNewswire/--HealthRoboticstodayannounce...pofselected,investors.ThisrecentlyformedToronto-ba...nada,Inc.andwillmarket,install,andsupport,HealthRo...,revolutionaryproductofferingsi.v.STATION(TM),i.v....lsoprovideassistanceonan"asneeded,basis"toitsstrat...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--CellTherapeutics,Inc.(CTI...AnnualPiperJaffrayHealthCareConference.Theconferen...el. ,, CTIwillpresentonTuesday,December1at11:00...stofCTI,spresentationwillbeavailableat www.cellthe...terwards. , ,PiperJaffrayHealthCareConference,New...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2